BTL Aesthetics debuts new EXION radiofrequency technology

Aesthetic device company BTL Aesthetics has introduced its new device EXION to the UK market.

According to the company, EXION treats the face, body and intimate area with four different applicators. BTL Aesthetics identifies the fractional radiofrequency (RF) applicator as the standout, combining AI-powered pulse control needling with monopolar RF.

The four applicators are the EXION Fractional RF, EXION Face which induces hyaluronic acid (HA) production through combined RF and ultrasound, EXION Body which targets skin laxity and fat loss within one applicator, and EMFEMME 360 which uses non-invasive RF to treat vaginal laxity and sexual dysfunction in eight minutes, according to the company.

Clinical trials have shown that EXION can induce a 224% increase in HA, 85% increase in skin laxity and 22% in fat reduction.

Zbynek Pistak, BTL Aesthetics’ managing director, said, “The innovation brought to the market by EXION is impressive and incredibly exciting. It not only enhances patient experience and outcomes, but also provides practitioners with multiple treatment possibilities in a single device. EXION is the result of BTL's extensive expertise in non-invasive technologies, perfectly addressing the industry's demand for highly effective outcomes with reduced recovery times.”

BTL Aesthetics is exhibiting at CCR 2023 on October 19-20 at ExCeL London. Click here to register for free today.